基于食品和药物管理局不良事件报告系统数据库对抗抑郁药物和发作之间的关系的分析
Dan Zou1, Qiaozhi Hu1, Lei Yu1
1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, PR China.
Clinics (Sao Paulo, Brazil)
|July 16, 2025
概括
这项研究发现14种抗抑郁药物与发作有关,布洛普显示的风险最高. 研究人员分析了数以百万计的不良事件报告,以了解抗抑郁药物的安全性和发作风险.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 抗抑郁药对治疗抑郁症至关重要,但由于安全问题而受到审查.
- 抗抑郁药使用与发作风险之间的联系需要进一步调查.
- 使用FAERS数据库,这项研究解决了抗抑郁药和之间的不清楚关系.
研究的目的:
- 评估在没有先前神经疾病的患者中,发作和各种抗抑郁药之间的关联.
- 为了确定特定的抗抑郁药,更高的倾向引起发作.
- 为了探索不同抗抑郁药物的不良事件发生的变化.
主要方法:
- 在FAERS数据库上进行了不成比例分析.
- 确定了与抗抑郁药物相关的发作的潜在风险指标.
- 报告几率比率 (ROR) 和信息组件 (IC) 方法都用于检测安全信号.
主要成果:
- 分析包括从2004年1月1日到2023年12月31日的15940383份不良事件报告.
- 14种抗抑郁药物与发作有显著的关联.
- 在研究中的抗抑郁药物中,布鲁的发作报告几率比率 (ROR) 是最高的.
结论:
- 14种抗抑郁药物与发作风险的增加显著相关.
- 布普罗被确定为抗抑郁药,根据ROR.根据ROR.根据ROR.根据ROR.根据ROR.根据ROR.
- 这些发现强调了监测特定抗抑郁药物治疗的风险的重要性.
相关概念视频
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Epilepsy and Seizures: Overview
285
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
285
Antiepileptic Drugs: Potassium Channel Activators
282
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
282
Antiepileptic Drugs: Glutamate Antagonists
521
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
521
Antidepressant Drugs: Overview
777
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
777
Antidepressant Drugs: MAOIs and Other Agents
372
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
372


